NCT06488209View on ClinicalTrials.gov

Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 29, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Healthy VolunteersAutoimmune Disease
Interventions
DRUG

LAD191

LAD191 SC injection.

OTHER

Placebo

Matching placebo SC injection.

Trial Locations (3)

19103

RECRUITING

Jennifer Parish, MD, Philadelphia

33165

RECRUITING

Doral Medical Research, Miami

78209

RECRUITING

ICON Early Phase Services, LLC, San Antonio

Sponsors

Lead Sponsor

Almirall, S.A.
All Listed Sponsors
lead

Almirall, S.A.

INDUSTRY